Search Within

Chung-Han Lee

Formats
  1. Meeting Abstract (79)
  2. Journal Article (63)
  3. Review (9)
  4. Research Letter (3)
  5. Book Section (2)
  6. Guidelines (1)
Groups
  1. Department of Medicine (157)
  2. Genitourinary Oncology Service (157)
  3. Solid Tumor Oncology Division (157)
  4. Weinberg Fellows (85)
  5. Department of Pathology and Laboratory Medicine (59)
  6. Population Sciences Research Program (59)

More Groups

People
  1. Robert Motzer (109)
  2. Martin Voss (75)
  3. Darren Feldman (55)
  4. Maria Carlo (55)
  5. Abraham Hakimi (42)
  6. Ritesh Kotecha (42)

More People

Years
  1. 2025 (4)
  2. 2024 (9)
  3. 2023 (19)
  4. 2022 (23)
  5. 2021 (20)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (63)
  2. Annals of Oncology (9)
  3. Clinical Cancer Research (6)
  4. Clinical Genitourinary Cancer (6)
  5. European Urology (5)
  6. European Urology Oncology (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (66)
  2. Oxford University Press (13)
  3. Elsevier Inc. (11)
  4. Nature Publishing Group (11)
  5. American Association for Cancer Research (9)
  6. Elsevier Science, Inc. (7)

More Publishers

Results (157)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors
    Journal Article

    Nykaza, I.; Murciano-Goroff, Y. R.; Desilets, A.; Harada, G.; Postow, M. A.; Callahan, M. K.; Lee, C. H.; Rudin, C. M.; Kelsen, D. P.; Stadler, Z. K.; more...
    The Oncologist (2025)

    Fulltext@MSK | Save
  • Multi-institutional analysis of immune-oncology combination therapy for metastatic MiT family translocation renal cell carcinoma
    Journal Article

    Ged, Y.; Touma, A.; Contreras, L. M.; Elias, R.; Van Galen, J.; Cupo, O.; Baraban, E.; Singla, N.; Lee, C. H.; Pal, S.; more...
    Journal of Immunotherapy (2025)

    Fulltext@MSK | Save
  • Clinical outcomes and targeted genomic analysis of renal cell carcinoma brain metastases treated with stereotactic radiosurgery
    Journal Article

    Ma, J.; del Balzo, L.; Walch, H.; Khaleel, S.; Knezevic, A.; Flynn, J.; Zhang, Z.; Eichholz, J.; Doshi, S. D.; Voss, M. H.; more...
    European Urology Oncology (2025)

    Fulltext@MSK | Save
  • Prospective study of patient, nursing, and oncology provider perspectives on telemedicine visits for renal cell carcinoma clinical trials
    Journal Article

    Doshi, S. D.; Knezevic, A.; Gonzalez, C.; Fischer, P.; Goodman, R.; Gornell, S.; Patel, S.; Puzio, C.; Ritea, A.; Lee, C. H.; more...
    Clinical Genitourinary Cancer (2025)

    Fulltext@MSK | Save
  • Nivolumab plus relatlimab and nivolumab plus ipilimumab for patients with advanced renal cell carcinoma: Results from the open-label, randomised, phase II FRACTION-RCC trial
    Journal Article

    Choueiri, T. K.; Kuzel, T. M.; Tykodi, S. S.; Verzoni, E.; Kluger, H.; Nair, S.; Perets, R.; George, S.; Gurney, H.; Pachynski, R. K.; more...
    ESMO Open (2024)

    Fulltext@MSK | Save
  • Lenvatinib plus Pembrolizumab following immune checkpoint inhibitor treatment in patients with metastatic clear cell renal cell carcinoma: Results from study 111/KEYNOTE-146
    Research Letter

    Lee, C. H.; Yogesh Shah, A.; Rao, A.; Taylor, M. H.; Di Simone, C.; Hsieh, J. J.; Pinto, A.; Gironés Sarrió, R.; Lee Cohn, A.; Asim Bilen, M.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Defining molecular features associated with microsatellite instability and response to immune checkpoint blockade in urothelial carcinoma
    Meeting Abstract

    Alam, S. M.; Teo, M. Y.; Woo, J.; Sarfaty, M.; Funt, S. A.; Aggen, D. H.; Lee, C. H.; Carlo, M. I.; Gandhi, J.; Ratna, N.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Associations of dietary fructose with survival of patients (pts) with metastatic cancer of the urothelium (UC) and renal cell carcinoma (RCC) on immune checkpoint blockade (ICB)
    Meeting Abstract

    Badri, A.; Guercio, B. J.; Ratna, N.; Gavrilov, D.; Metzker, N.; Duzgol, C.; Teo, M. Y.; Regazzi, A. M.; Supplice, L.; Funt, S. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Cabozantinib plus nivolumab in patients with non–clear cell renal cell carcinoma: Updated results from a phase 2 trial
    Journal Article

    Fitzgerald, K. N.; Lee, C. H.; Voss, M. H.; Carlo, M. I.; Knezevic, A.; Peralta, L.; Chen, Y.; Lefkowitz, R. A.; Shah, N. J.; Owens, C. N.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214
    Journal Article

    Mantia, C. M.; Jegede, O. A.; Plimack, E. R.; Powles, T.; Motzer, R. J.; Tannir, N. M.; Lee, C. H.; Tomita, Y.; Voss, M. H.; Choueiri, T. K.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save